2012•Journal of the American College of CardiologyOpen access

VALIDATION AND QUANTIFICATION OF GENETIC DETERMINATION OF LIPOPROTEIN (LP)(A) LEVELS AND PREDICTIVE VALUE FOR ANGIOGRAPHIC CORONARY ARTERY DISEASE (CAD)

Jeffrey L. Anderson, Stacey Knight, Benjamin Davies Horne, Tami L. Bair, John A. Huntinghouse, Jeffrey S. Rollo, Heidi Thomas May, Joseph Brent Muhlestein, John F. Carlquist

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Coronary artery disease, Predictive value, CAD, Lipoprotein(a), Cardiology, Internal medicine, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
VALIDATION AND QUANTIFICATION OF GENETIC DETERMINATION OF LIPOPROTEIN (LP)(A) LEVELS AND PREDICTIVE VALUE FOR ANGIOGRAPHIC CORONARY ARTERY DISEASE (CAD) — Research Paper | ScholarLens